Aadi Bioscience Inc (AADI) Actualités

Form DEFM14A - Definitive proxy statement relating to merger or acquisition

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form PREM14A - Preliminary proxy statements relating to merger or acquisition

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update PR...